Latest Feature Articles
Pharma disputes, fines, and the work of the CMA
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |
Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …
Personalised medicine in oncology: Where are we now?
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Cancer, oncology, presonalised medicine, surgery
The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Exploring the potential of drug repurposing
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | drug repurposing
Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
Biosimilars and Brexit: What’s in store for UK’s biosimilar market?
June 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biosimilars, brexit
It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …
The importance of representation in clinical trials
June 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Representation, clinical trials
Before any kind of new medicine can be made available to the market, it has to go through a strictly …
Are we on the cusp of an AI revolution?
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |
The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …
Navigating through the post-COVID-19 R&D bottleneck
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |
Jack Goddard inve
The Truth Behind the £1.8 Million Drug
March 31, 2021Manufacturing and Production | FDA, NHS, NICE
As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug …
Real-world evidence and clinical research diversity
March 31, 2021Research and Development | rwe
Clinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what …
MAPs during a global pandemic
February 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, MAPS
Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
How COVID-19 has changed pharmacovigilance
February 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, pharmacovigilance
The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
How COVID-19 has affected the oncology drugs market
January 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, Cancer
In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
The importance of ethics and patient centricity in managed and early access programmes
December 21, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |
Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
How COVID-19 is affecting diabetics and their access to insulin in America
December 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |
Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …
How the US election could affect the pharmaceutical industry
November 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Donald Trump, Joe Biden, Trump, US, US election 2020, pharma
The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
